Pharmafile Logo
Pharmafocus logo
Advanced Search
6813384933_1fb31d73fb_z

HIV on the rise among straight men in Australia

September 24, 2018
Medical Communications, Sales and Marketing AIDS, Aboriginal, Australia, HIV, Kirby Institute

The number of new HIV diagnoses is on the rise among heterosexual men in Australia, according to a new report …

News
7359dba7-e1da-4eb4-8765-58da6178899b

Sarepta’s Exondys 51 hit with negative CHMP opinion in Duchenne muscular dystrophy

September 24, 2018
Research and Development, Sales and Marketing CHMP, Duchenne Muscular Dystophy, EMA, Europe, Exondys 51, pharma, sarepta

Sarepta Therapeutics has been rocked by a hurdle in its pursuit of regulatory approval in Europe, as the company revealed …

News

Courts back NHS in fight against Novartis and Bayer

September 24, 2018
Sales and Marketing Bayer, Eylea, NHS, Novartis, avastin, ludentis

The NHS has won a court case against multinational pharmaceutical firms Novartis and Bayer, after the companies sought to block …

News
calvarycemeteryqueens_edit

Life expectancy falls in America; drugs, alcohol and suicide to blame

September 24, 2018
Sales and Marketing USA, alcohol, drugs, health, opiod crisis, suicide

Life expectancy has fallen for the second year in a row for people in the United States, according to new …

News
astrazeneca-sign

AstraZeneca’s Farxiga cuts heart risk in type 2 diabetes patients

September 24, 2018
Research and Development, Sales and Marketing AstraZeneca, diabetes, farxiga, pharma

AstraZeneca has unveiled new Phase 3 data for its SGLT2 inhibitor Farxiga (dapagliflozin), showing with the drug demonstrating positive findings …

News
humira_abbott__4

EU approval for Mylan and Fujifilm’s Humira biosimilar

September 21, 2018
Medical Communications, Sales and Marketing EU, Europe, Humira, Mylan, biosimilar, pharma

The European Commission has approved its fifth biosimilar of the world’s best-selling drug, Abbvie’s Humira (adalimumab), granting marketing authorisation to …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

September 21, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jobs, Novartis, Novo Nordisk, Senate, UCB, manufacturing, opioid crisis, top 10

Manufacturing took a hit this week as Novo Nordisk announced the loss of 400 jobs while Novartis made the move …

News

ABPI forges five year partnership with AHSN focused on increased uptake of transformative biomedical innovations into the NHS

September 21, 2018
Medical Communications ABPI, NHS, UK, ahsn, collaboration

The Association of the British Pharmaceutical Industry (ABPI) has announced that it is forging a five year partnership with the …

News
1920px-hiv-budding-color

British MPs call for HIV prevention PrEP drugs to be made available on NHS in England

September 21, 2018
Medical Communications

PrEP drugs – pre-sex drugs that are able to dramatically reduce the chances a person has of contracting HIV – …

News
opioid_pills

Surgeon General calls for cultural shift in approach to opioid crisis

September 21, 2018
Medical Communications Trump, US, opioid crisis, opioid epidemic, surgeon general

The Surgeon General of the United States has called for a cultural shift in the way in which Americans talk …

News

Shares in Molecular Templates surge after the announcement of Takeda collaboration

September 20, 2018
Business Services, Research and Development Molecular Templates, Shares, Takeda, markets, stocks

Shares in the Texas based biotech Molecular Templates have soared after the company announced that they would be collaborating with …

News
alzheimers_pharmafocus_accompanying_image

A goal in mind: Transforming the way Alzheimer’s disease is diagnosed and treated

September 20, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Roche, pharma

Dr Rachelle Doody, Global Head of Neurodegeneration at Roche/Genentech, discusses key learnings from clinical trials in Alzheimer’s disease, and how …

Feature

Astellas’ chronic kidney drug shows superiority at Phase 3

September 20, 2018
Research and Development Astellas, chronic kidney disease, pharma, roxadustat

Astellas has revealed new Phase 3 data for roxadustat in the treatment of chronic kidney disease (CKD) in patients with …

News
white-house-13863_960_720

Senate bill would save money and allow generics to reach market more quickly, according to CBO report

September 20, 2018
Business Services, Medical Communications, Sales and Marketing CBO, Senate, US, biosimilars, generics, law, politics

The Congressional Budget Office (CBO) has said in a report that a bipartisan bill awaiting a vote in the senate …

News
sicorbio

FDA greenlights Teva’s migraine drug Ajovy in two dosage options

September 20, 2018
Sales and Marketing FDA, Teva, US, ajovy, migraine, pharma

Israeli drugmaker Teva has announced that its calcitonin gene-related peptide (CGRP) inhibitor Ajovy (remanezumab-vfrm) has received FDA approval as a …

News
merckwindow_web

MSD to launch Keytruda at half US list price in China

September 20, 2018
Business Services, Sales and Marketing BMS, China, MSD, global, keytruda, markets, pricing

US pharma giant MSD will offer cutting edge cancer treatment Keytruda to Chinese patients at half the price at what …

News
almirall-605x338

Almirall’s Ilumetri scores EU approval in chronic plaque psoriasis

September 19, 2018
Research and Development, Sales and Marketing Almirall, EADV 2018, Ilumetri, pharma, psoriasis

Hot on the heels of the European Academy of Dermatology and Venereology Congress (EADV) 2018 where psoriasis took centre stage, …

News
kymriah

NICE rejects CAR-T therapy Kymriah for DLBCL in adults

September 19, 2018
Research and Development CAR T, CAR-T, Kymriah, NICE, Novartis, leukaemia

The National Institute for health and Care Excellence (NICE) has rejected Novartis’ CAR-T therapy Kymriah for use in adults with …

News

Novartis to relocate Arnhem operations to Amsterdam, 400 jobs affected

September 19, 2018
Manufacturing and Production, Research and Development Netherlands, Novartis, amsterdam, pahrma, pharma

Novartis has announced it is to relocate its operations in Arnhem in the Netherlands to the capital city of Amsterdam, …

News
astrazeneca_plaque

AstraZeneca to increase presence in China

September 19, 2018
Research and Development AstraZeneca, China, alibaba, governemnt, tencent

The Anglo-Swedish multinational AstraZeneca is moving towards becoming a major healthcare provider in China as part of an effort to …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026